Quotient Clinical has extended its Translational Pharmaceutics platform into cancer drug development, employing its real-time manufacturing capabilities to supply drug products to support first-in-patient and proof-of-concept programs.   Translational Pharmaceutics integrates real-time drug product manufacturing and clinical testing, using processes designed to reduce the timelines and cost of early stage drug development. Quotient has applied this platform in early development programs at its o...